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This paper juxtaposes changes over the last forty years in income growth and 
distribution with the mortality changes recorded at the aggregate level in about 170 
countries and at the individual level in 26 countries with at least two demographic and 
health surveys covering the last twenty years. Over the 1980s and 1990s, the infant 
mortality rate, under-5 mortality rate, and life expectancy at birth mostly continued the 
favourable trends that characterized the 1960s and 1970s. Yet, especially in the 1990s, 
the pace of health improvement was slower than that recorded during the prior decades. 
In addition, the distribution between countries of aggregate health improvements 
became markedly more skewed. These trends are in part explained by the negative 
changes recorded in sub-Saharan Africa and Eastern Europe, but are robust to the 
removal of the two regions from the sample. This tendency is observed also at the 
intraregional level, with the exception of Western Europe. Thirdly, demographic and …/  
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health survey data for 26 developing countries point to a frequent divergence over time in 
the within-country distribution of gains in the infant mortality and under-5 mortality 
rates among children living in urban versus rural areas and belonging to families part of 
different quantiles of the asset distribution. The paper concludes by underscoring the 
similarities and linkages between changes in income inequality and health inequality 
and suggests some tentative explanations of these trends without, however, formally 
testing them. 
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1 Introduction 
The debate on the pace of improvement and convergence in levels of wellbeing between 
and within countries has acquired a particular relevance during the recent decades of 
economic liberalization and globalization. Though trends in wellbeing can be—and 
indeed are—affected by non-economic and non-policy factors, sustained improvements 
and convergence over time in wellbeing indicators across and within countries could be 
interpreted as an indication of the success of the liberal approach to policy making 
(Dollar 2001). In turn, slow progress and growing divergence might reinforce the claims 
of the critics who argue that globalization is inefficient and that—both globally and 
within each nation—it mainly benefits the upper income groups. The attention received 
by this debate in policy circles has substantially soared with the adoption of the 
Millennium Development Goals (MDGs) that have set clear targets for many indicators 
of wellbeing, including health wellbeing indicators such as infant mortality rate (IMR) 
and under-five mortality rate (U5MR). The explicit inclusion of health indicators among 
the MDGs is essential for various reasons. Health is a fundamental dimension of human 
wellbeing, good health is instrumental for improving other dimensions of wellbeing, 
and intertemporal and inter-country comparisons based on health wellbeing indicators 
are less fraught with statistical problems than comparisons effected, for instance, in the 
monetary space. For all these reasons, this paper focuses on changes in the level and 
distribution of health wellbeing.  
 
An analysis of changes in health wellbeing can also help shedding light on trends in 
income wellbeing. In this regard, while the pace of improvement of income per capita 
over the 1980s and 1990s shows a marked deceleration and an increase in regional 
variation in relation to the two preceding decades,1 and while the distribution of within-
country income per capita worsened in most countries,2 the trend in between-country 
inequality are unclear, as results of alternative analyses differ considerably depending 
on the type of statistical assumptions on which these rest.3 In contrast, analyses of 
                                                 
1 The global growth rate of GDP per capita slowed from 2.6 per cent per annum over the 1960s and 
1970s (the second Golden Age of Capitalism) to 1.3 per cent over the 1980s and 1990s (the second Era of 
Liberalization and Globalization). Growth was particularly weak in the 1990s owing to stagnation in 
Europe and Japan, the collapse of the European economies in transition, the persistent difficulties faced 
by Latin America and sub-Saharan Africa, slow growth in MENA and, to a lesser extent, the Asian 
financial crises. In contrast, China and India recorded rapid growth following the adoption of gradual, 
pragmatic and selective economic reforms.   
2 Cornia (2004) suggests that income inequality rose—though by different extents and with different 
effects on wellbeing—in 53 of the 73 countries analysed, including China, India, Indonesia, the USA, 
Japan and Russia. Only in nine small and medium-sized countries inequality appears to have fallen, and 
only in 16 it remained constant. These country-based results are confirmed by aggregate studies 
(Bourguignon and Morrisson 2002).  
3 Results depend crucially on the inequality index chosen, the period of analysis considered, the ‘correct 
measurement’ of the Chinese rate of growth, the weighing of results by population size, whether the 
comparison is carried out on the basis of GDP per capita (derived from the national accounts) or 
disposable income per capita (derived from household surveys), and whether the conversion of national 
GDP values into dollars is done by means of the market or PPP exchange rate. Results depend also on 
whether the country distributions of income are computed by assigning the same income per capita to all   2
health wellbeing are less susceptible of identification, methodological and measurement 
biases. While problems persist also in this approach, results of analyses of convergence 
in health wellbeing are less controversial than those based on income wellbeing and 
could therefore help to investigate on overall trends in wellbeing and the distributive 
effects of the present development pattern.  
2  Valuing changes in wellbeing  
Traditionally, economists measure wellbeing in the monetary space. In this type of 
analysis, gains (losses) of wellbeing are associated with a rise (decline) in average 
incomes or consumption per capita, or with increases in the number of people emerging 
from (falling into) poverty.  
 
While widely applied, this approach suffers from considerable theoretical and 
information problems and can, particularly during periods of structural transformation, 
lead to erroneous conclusions. To start with, unlike in the case of health indicators, 
which are a direct measure of wellbeing, incomes and wealth are just an input to human 
wellbeing. However, there are several other factors that influence health wellbeing or 
education wellbeing, including household assets, human capital, time use, structure and 
stability of the family, health practices, income inequality and instability, relative prices 
of essential goods, and public health expenditure. A large number of studies find a 
positive correlation between income level and health status, but this relation is not linear 
and unstable and shows a large unexplained variance around the mean. Also, changes in 
household income normally trigger a series of household and collective responses which 
can cushion it from the negative health effects of income falls. Indeed, it is not 
uncommon to observe improvements in health indicators concomitantly with declines in 
household incomes or, symmetrically, a decline in average health wellbeing and 
growing health inequality during periods of income growth. Finally, contrary to the 
common perception, income is not easily definable or measurable, especially in 
economies with a large subsistence or informal sector and during periods of high 
inflation, radical fluctuations in relative prices and rapid structural change.  
 
Measurement of average wellbeing and of its distribution among the population, as well 
as cross-country comparisons, faces fewer methodological problems and does not 
require the adoption of arbitrary hypotheses and statistical conventions. In addition, the 
definition and meaning of the variables used—infant mortality rate and life expectancy 
at birth—is less ambiguous than that of monetary aggregates. Nevertheless, also in this 
case, national estimates and international comparisons can be complicated by 
methodological and data availability problems that are briefly reviewed hereafter. The 
major problem is limited data availability and quality. Vital registration coverage is 
                                                                                                                                               
citizens, relying on a synthetic statistic such as the Gini coefficient, or building the distribution of income 
on the basis of micro-data. Finally, results depend on the treatment of large dualistic countries such as 
China and India, and the inclusion of the ‘special case’ of China in the calculation of between-country 
inequality. In contrast, results point to a clear North-South polarization when between-country inequality 
is assessed not as a ratio of the countries’ respective GDPs per capita but as their absolute difference. 
This aspect of income polarization has, however, been neglected by most of the literature.    3
complete or almost complete only in high-and middle-income countries, and only one 
third of all adult deaths are actually registered.4 In most low-income countries, 
registration of vital statistics is incomplete, often massively so, and mortality data are 
estimated by means of life survival tables or by extrapolating past trends. Infant and 
child mortality are also estimated indirectly from censuses or demographic surveys by 
means of retrospective techniques.5 The stability and reliability of these estimates can 
however be affected by large sampling error, limited sample size and, in low mortality 
countries, low frequency of infant and child deaths. As a result, it is not uncommon to 
observe large discrepancies between mortality estimates originating from surveys and 
register data.  
 
The use of life expectancy at birth (LEB) as an indicator of health wellbeing poses 
additional problems of interpretation. Such an indicator is in fact computed on the basis 
of the age specific mortality rates observed for different cohorts at a moment in time. 
However, as noted in Pradhan et al. (2001), such rates do not reflect the real life chances 
of a person born in the reference year, as computation of such index would require to 
know her future risks of death at different ages. As a consequence, LEB does not refer 
to any individual birth cohort but rather to a hypothetical cohort facing the age specific 
death rates observed at the present time.  
 
The paper does not concentrate only on average aggregate changes in indicators of 
health wellbeing but examines, within the limitations imposed by data availability, also 
the changes intervened in their distribution between and within countries. Steep health 
differentials have been observed for long in many countries. In the United Kingdom, for 
instance, the famous Black Report6 focussed on the marked health gradient observed 
among different groups of civil servants. Concern for reducing inequality in health was 
evident also in the WHO ‘Health for All’ strategy and the related target setting exercises 
that in 1984 posited that ‘… by the year 2000, the actual differences in health status 
between countries and between groups within countries, should be reduced by at least 
25%’ (Whitehead 1990, cited in Gwatkin 2000). Meanwhile, concern for the health 
impact of economic policies intensified with the introduction of structural adjustment 
programmes that may have shifted the policy focus away from the search of ‘health for 
all’ and the achievement of the MDGs. 
 
Finally, an emphasis on health differentials is justified by several arguments. First, 
according to most theories of justice, an average improvement in IMR or LEB 
characterized by high variation around the mean receives a lower social valuation than 
an equal average improvement characterized by a more egalitarian distribution. Second, 
targeting health intervention on the deprived groups generally permits achieving faster 
average gains than if it were targeted at the general population. For instance, high rates 
of child and adult mortality in poor rural areas can be reduced by low-cost public health 
                                                 
4 WHO (2005). 
5 UN (2004). 
6 Black et al. (1980).   4
interventions, while the further reduction of already low mortality rates in urban areas is 
costly and difficult to achieve. Greater equity in health can thus be a source of greater 
aggregate efficiency. Third, large health differentials, or their increase over time, may 
exacerbate the perception of unfairness of social relations and raise political instability. 
Finally, a rise in health differentials, or their persistence at high levels, collides with the 
emphasis placed by the Human Rights Convention (HRC) on the wellbeing of every 
individual. Rapid improvements limited only to a few groups and to the average do not 
satisfy the prescriptions of the HRC and MDGs.  
3  Literature on changes in health wellbeing and its distribution  
3.1  Pace of improvement in health wellbeing 
Most of the literature in this area examines the pace of changes over the last two 
decades without comparing it to that realized over prior decades. In reviewing changes 
in IMR, LEB and life expectancy at age 1, for instance, Fox (1998) emphasizes that 
progress continued uninterrupted for all these indicators for both developing and 
developed countries, but does not assess whether these gains took place at a similar, 
faster or slower pace than in the past. Likewise, in analyzing changes in LEB over 
1980-2000, Goesling and Firebaugh (2004) note that the increase in LEB in the 1990s in 
rich countries was smaller than that recorded in the developing countries but do not 
compare it with that recorded over the prior two decades. In contrast, Wagstaff and 
Cleason (2004) note that, in the 1990s, progress in U5MR reduction was slower than in 
the 1980s, while Deaton (2004) points to a worldwide reduction in the rate of decline of 
child mortality and to slower gains in child mortality in many countries. In turn, Deaton 
and Drèze (2002) underscored that in India IMR declined in the 1990s by only 12.5 per 
cent as against 30 per cent in the 1980s. Also the World Development Report 20067 
points to a slowdown in the rate of increase in LEB during the 1990s. 
3.2  Between-country convergence in health wellbeing 
Over the past three decades, most demographers predicted growing convergence in 
health wellbeing between developing and developed countries. Wilson (2001), for 
instance, found that LEB had steadily converged across countries starting from 1950. 
Meyer (2001), in turn, focused on club convergence, by emphasizing that the 
(unweighed) distribution of LEB across countries remained twin-peaked over 1960-97 
despite the ‘migration’ of several countries from the left to the right peak and the 
increase in the mode of the two components of this bi-modal distribution. Thus, 
convergence towards a life expectancy of 45-50 years was evident within the low-LEB 
club of poor countries and 75-80 years within the high-LEB club of rich ones. 
 
In turn, Micklewright and Stewart (1999) found that the standard deviation of the 
distribution of U5MR of the 15 members of the European Union declined over 1970-95 
                                                 
7 World Bank (2005).   5
by 90 per cent as death rates in the countries of southern Europe moved closer to those 
of northern Europe. Convergence was also found, if less markedly, for the mortality rate 
of children of 5-14 years of age. This convergence was to a considerable extent policy-
driven. Indeed, the EU Cohesion Fund has provided structural and regional funds 
equivalent to 3-4 per cent of the GDP of the recipient countries to help them catch up 
with the EU average. Participation in the EU favoured the convergence in health 
wellbeing also through the compulsory adoption of advanced standards—the so-called 
acquis communautaires—in the field of health services.  
 
In contrast, the most recent analyses point to growing between-country health inequality 
owing to the dramatic rise in mortality rates recorded in sub-Saharan Africa (SSA)and 
Eastern Europe, the slow gains recorded in China despite a quadrupling of GDP/c over 
1980-2000, and poor health performance of other countries. In this regard, Goesling and 
Firebaugh (2004) analyze the distribution of LEB of 169 countries for the period 1980-
2000. They note that while increasing during the 1980s in all regions, LEB declined 
over 1990-2000 in SSA and the transition economies. These divergent paths have led to 
a polarization of the country distribution of LEB, as confirmed by the upward trend 
recorded since 1992 in four synthetic indexes of the distribution of life expectancy. 
According to the authors, LEB inequality declined until 1992 to increase significantly 
between 1992-2000. A decomposition of this inequality rise into changes in population 
shares and life expectancy ratios led them to conclude that—although only one-tenth of 
the world’s population lives in SSA—the HIV/AIDS impact on LEB (-3.5 years on 
average, as opposed to a worldwide increase of 1.2 years) was the main factor in LEB 
divergence. When SSA was removed from the sample, the divergence in national LEB 
disappeared as the fall in life expectancy in the transition economies was compensated 
by the rapid rise recorded in populous India.  
 
Also McMichael et al. (2004) also find evidence that contradicts the finding about LEB 
convergence. They identify in fact three sets of countries, the first (composed mainly of 
advanced nations) with a plateauing LEB trend, a second group of middle-income 
countries converging rapidly towards the LEB of the advanced nations, and a third 
group comprising at least 42 countries (mostly from SSA and the economies in 
transition, but including also the Bahamas, the Dominican Republic, Fiji, Haiti, 
Honduras, Iraq, and North Korea) that exhibited in 2001 a lower life expectancy than in 
1960, 1980 or 1990. In their view, the usual explanation of health convergence—i.e., 
the rapid fall in deaths due to infectious diseases in poorer countries and the slower 
decline in mortality due to chronic diseases—has to be broadened so as to take into 
account new life-threatening challenges faced in the economic, social and 
environmental areas. 
3.3  Within-country convergence in health indicators and mortality differentials 
Health differentials are observed in practically all countries, including the most 
advanced ones. One of the most important IMR differentials is that by level of 
education of the mother (Caldwell 1979). Greater education among mothers is also   6
found to reduce the IMR gender differential.8 Mortality rates also correlate strongly 
with the region and, in particular, the type (rural or urban) of residence, that proxy 
different access to sanitation, housing, health and educational services.9 Health 
differentials by income level are equally marked.10  
 
Another point, central to the analysis of this paper, is that in more egalitarian countries, 
mortality differentials are not as glaring as in unequal societies. Hardly ever a class-, 
gender- and region-neutral development policy is able to reduce mortality differentials, 
even in the presence of sizeable average improvements. For instance, an analysis of 
survey data on inequalities in U5MR by consumption quintiles found statistically 
significant inequalities in most of the nine countries analyzed.11 Such differentials were 
particularly pronounced in highly unequal Brazil where an IMR concentration index of 
-0.322 was found. In contrast, the index was -0.016 in Vietnam and -0.028 in Ghana, i.e. 
countries where consumption inequality was less pronounced. In turn, Wilkinson (1996) 
compared IMR by social class in England and Wales versus Sweden, and discovered a 
marked social gradient in the first countries but not in Sweden, a country strongly 
committed to reducing health inequality.  
 
Growing U5MR differentials by income level are reported by Minujin and Delamonica 
(2003) on demographic and health survey (DHS) data for the 1980s and 1990s for 24 
developing countries. In the 1980s the ratio of the U5MR of children of families 
belonging to the bottom 20 per cent of the household ‘asset’12 distribution to that 
children of households belonging to the top 20 per cent ranged between 1.3 to 4.7, with 
an average of 2.2. However, over the next ten years the ratio worsened in 11 of the 24 
countries studied, remained constant in 10 and improved in three. Such trend was 
observed not only in countries where the average U5MR worsened or stagnated, but 
also in half of those where it fell. In these countries, the average U5MR reduction was 
mostly driven by a decline in child mortality among middle- and high-income groups. 
Meanwhile, the reduction among the poor was lower or statistically not different from 
zero.  
 
A recent analysis of IMR differentials in China making use of census and survey data 
by Zhang and Kanbur (2003) found that, while the nationwide IMR declined sharply 
from the 1960s to the 1980s, it then levelled off or was reversed in recent times due to 
the surge in rural IMR from 37 to 44.8 per thousand between 1981 and 1995. As a 
result, the ratio of rural to urban IMR rose from 1.5 to 2.1, the female to male IMR ratio 
                                                 
8 Murthi et al. (1995). 
9 Sastry (1996); Jhamba (1999). 
10 Rutstein (2000). 
11 Wagstaff (2000). 
12 The ‘asset index’ is used to proxy household wealth and income and is used to stratify households into 
quintiles. It is constructed following the procedure described in Filmer and Pritchett (1998) that weights 
the possession of certain household durables (such as radios and bicycles), the quality of dwellings (as 
revealed by the type of roof and floor) and access to different kinds of water and sanitation facilities.     7
rose from 0.9 to 1.3, and the Gini index of the regional distribution of IMR worsened. 
The authors explain these trends to the fiscal decentralization of 1978, the dismantling 
of commune-based health services, the introduction of private care in 1984 and the 
freedom granted to urban-based state-owned enterprises (SOEs) to lay off workers and 
cut health subsidies. The authors conclude by noting that, given the weakness of safety 
nets and social insurance arrangements and limited fiscal power of villages, it was to be 
expected that increases in income inequality would translate into increasing health 
inequality.  
4  Trends in the pace of improvement in health wellbeing 
Conscious of the methodological and data problems encountered in measuring health 
wellbeing, the values for the IMR, U5MR and 100-LEB (see later) were compiled for 
the years 1960, 1970, 1980, 1990, and 2000 for 168 countries on the basis of the World 
Development Indicators of the World Bank (2004). Missing data for several former 
communist countries of Europe were filled in on the basis of the data included in the 
UN Population Prospects 2002 revision.13 Average, population weighted, compounded 
rates of change over the 1960s, 1970s, 1980s and 1990s were then computed for all 
main regions and country groupings, and for China and India separately. Analysis of 
these data points to the following results: 
4.1  A widespread decline over the 1990s in the pace of improvement in 100-LEB  
An analysis of changes over time in LEB risks leading to a biased conclusion as the 
variable LEB is upper bounded at, say, 100 years of age14—a fact that automatically 
forces smaller absolute and relative gains in countries with an already high life 
expectancy. Thus, barring cases of extreme deteriorations, this method of calculation is 
unable to provide a balanced picture of the real progress realized in overall survival. To 
avoid this problem, typically met in measuring progress in upper bounded variables, it 
was necessary to calculate the average annual compounded rate of change of the 
difference between 100 (the arbitrarily assumed upper bound of LEB) and its observed 
values. The variable 100-LEB measures the ‘life years lost in relation to the maximum 
attainable LEB’ and has the advantage of being scale invariant, which means that rates 
of improvement are independent from the base value of the variable. For instance, in 
this framework, a two-year rise in LEB in a country with a LEB of 80 years generates a 
10 per cent improvement, that is identical to that generated by a rise of 6 years in a 
country with a LEB of 40.  
                                                 
13 See UNPD (2002). 
14 Such upper bound is arbitrary, as the maximum attainable life duration varies over time and across 
countries with the development of medical technologies and other factors. Over the medium term, 
however, it is undeniable that we face some kind of immutable genetic maximum that cannot be changed 
by an increase in resources or medical services. While the choice of 100 is arbitrary, the results of the 
analysis would not change much if instead an upper bound of, say, 90 or 110 years had been chosen (see 
later).   8
Table 1: Levels and annual population-weighed percentage average rates of change in 
(100-LEB) by main regions and key countries, 1960-2000 
  Levels  Average annual rate of change 
  1960 1970 1980 1990 2000  60-70  70-80  80-90  90-100 
High-income  countries  31 29 26 24 22  -0.64  -1.04  -0.86  -0.84 
Low- and middle-income countries:   56  45  40  37  36  -2.14  -1.12  -0.80  -0.35 
   Low- and middle-income excl. China, India  51 46 41 38 38  -1.03  -1.08  -0.79  -0.14 
Macro  regions*             
   East Asia and Pacific*  61**  41  36  33  31  -3.94**  -1.37  -0.83  -0.56 
      China  64**  38  33  31  30  -4.97**  -1.42  -0.63  -0.45 
      East Asia and Pacific excl. China  54  48  42  37  34  -1.14  -1.35  -1.30  -0.85 
   Eastern Europe and Central Asia    35 32 32 31 32  -0.73  0.06  -0.52  0.28 
   Latin America and Caribbean  44  40  35  32  30  -0.99  -1.10  -0.98  -0.78 
   Middle East and North Africa  53 48 42 36 32  -1.06  -1.29  -1.58  -1.05 
   South Asia  56  51  46  42  38  -0.92  -0.97  -1.11  -0.99 
      India  56  51  46  41  37  -0.94  -0.99  -1.14  -0.97 
      South Asia excl. India  58  53  48  44  39  -0.86  -0.91  -1.03  -1.08 
   SSA   60  56  52  50  53  -0.68  -0.63  -0.45  0.66 
             
World  50*  41 37 35 34  -1.83*  -1.00  -0.74  -0.36 
World excl. SSA  48*  40  36  33  31  -1.91*  -0.92  -0.86  -0.62 
World excl. SSA and EECA  50*  41  37  33  31  -2.04*  -1.06  -0.88  -0.71 
Source: Authors’ calculations based on World Bank (2004), integrated with data from UNPD (2002). Notes: *High 
income countries are not included in the macro regions, e.g. East Asia does not include Japan; **these values are 
influenced by the famine that hit China during the 1958-62 ‘Great Leap Forward’. 
 
Table 1 presents trends in 100-LEB and its annual compounded percentage rate of 
change.15 It documents the rapid gains recorded over the 1960s and 1970s thanks to the 
development of national health systems and the adoption of modern health technologies 
in newly independent states. In the socialist countries of Europe such gains were less 
pronounced and indeed they stagnated in 1970s due to ‘chronic stress’16 while in the 
1990s 100-LEB rose markedly because of a sharp rise in cardiovascular and violent 
deaths caused by ‘acute stress’ induced by a difficult transition to the market 
economy.17 As a result, in 2000 100-LEB in this region was the same as in 1970. The 
table documents also the massive loss of life expectancy caused in SSA by HIV/AIDS 
and, to a lesser degree, by economic stagnation, eroding health services, rising 
inequality and local conflicts. The table also show that the rate of decline in (100-LEB) 
                                                 
15 The regional averages and the measures of dispersion presented in the paper are always weighted by 
the appropriate populations (live births for IMR, the whole population for 100-LEB, etc.). Trends in the 
unweighted averages and inequality measures are mostly omitted for reasons of space. As expected, they 
show a greater variability than the weighted ones, though they broadly confirm the trends identified 
above. 
16 Bobak and Marmot (1996). 
17 Cornia and Paniccià (2001).   9
varies considerably across regions, and that the best results were achieved in the 1960s 
in Africa and Eastern Europe, the 1970s in East Asia, Latin America and the high-
income group, the 1980s in MENA and India and the 1990s in the South Asian 
countries other than India (thanks to the rapid mortality decline recorded in 
Bangladesh). 
 
The main message of Table 1 concerns, however, the steady and generalized decline in 
the rate of progress in 100- LEB, a decline that is robust to the removal of SSA and 
Eastern Europe from the sample and to the change of the upper bound of LEB from 100 
to 90.18 Besides the cases of Eastern Europe and SSA, a marked slowdown in relation 
to the prior decade is evident also in China and the East Asian economies, and a less 
pronounced one in Latin America, MENA and India. In contrast, the slowdown 
recorded in high-income countries is modest, suggesting the possibility of continued 
gains even at low levels of 100-LEB. The second main message is that such slowdown 
was most pronounced in the 1990s, possibly suggesting, with the exception of South 
Asia, the impact of systemic development problems or the impact of covariant random 
shocks. 
4.2  A fairly widespread decline over the 1990s in the rate of improvement in IMR 
Table 2 presents the rates of change of IMR over the period 1960-2000. In many 
developing countries, infant deaths represent a large share of total deaths, and IMR is 
considered a key indicator of overall health. U5MR is an even more accurate predictor 
of overall health, but information on such variable is available for only 156 countries. 
For this reason, as well as for reasons of space, the paper presents only the results of the 
analysis of IMR trends.19  
 
As noted in Fox (1998), the last two decades witnessed a continuation of the 
improvements in child health indicators recorded over 1960-80. In fact, the 1980s 
recorded the fastest decadal rate of decline in IMR in Latin America, MENA and India, 
while acceptable rates of IMR decline were sustained in East Asia, Eastern Europe and 
the high-income countries. The fast IMR decline in Latin America and MENA during 
the 1980s is both remarkable and puzzling, in view of the recession experienced by both 
regions and of the debt, budgetary and inequality crises suffered by Latin America.20 
Continued progress was likely due to a rise in parental literacy and female education. 
An even greater role was played by the spread of low-cost health technologies and 
community-based approaches to health, among which immunization and oral 
rehydration played an important part. As shown in Figure 1, the coverage of DPT3 
                                                 
18 The rates of improvement are sensitive to the choice of the upper bound. Yet, the conclusions do not 
change significantly in case the arbitrary upper bound chosen is 90, so as to generate the variable 90-LEB, 
that is ’the life years lost in relation to the maximum attainable LEB of 90’.  
19 The U5MR analysis is available from the authors. Its results support the conclusions of the IMR 
analysis.    
20 In contrast, in MENA the public health expenditure/GDP ratio remained at a high 4-5 per cent of GDP 
during the entire decade. In addition, the region recorded a massive rise in female education made 
possible by generous allocations of public funds to education staring from the 1970s.   10
immunization rose in Latin America from below 40 per cent in 1980 to 75 per cent in 
1990. In MENA, the expansion was even more rapid. In India, progress in 
immunization in the 1980s was accompanied by a widespread and fairly egalitarian 
growth. Table 2, however, also shows that the rate of IMR reduction fell in the 1990s in 
all but two regions. In China, India, MENA and Eastern Europe the fall was sizeable. 
The decline is evident also at the global level, and is robust to the elimination of SSA 
and Eastern Europe from the sample.  
Table 2: Levels and annual average population-weighed average percentage rates of 
change in IMR by main regions and key countries, 1960-2000  
 
Levels 
Average annual rate of 
change 
  1960 1970 1980 1990 2000   60-70  70-80  80-90  90-00 
High-income  countries  36  22  12  8  6    -4.8 -5.9 -4.0 -2.8 
Low- and middle-income countries:   138  107  86  69  62    -2.5  -2.2  -2.2  -1.1 
   Low- and middle-income excl. China and India  129  111  94  75  70    -1.4  -1.7  -2.2  -0.7 
Macro  regions*              
   East Asia and Pacific*  134**    85    56    43    34    -4.4**  -4.1  -2.6  -2.3 
      China  150*    85    49    38    32    -5.5*  -5.4  -2.5  -1.7 
      East Asia and Pacific excl. China    91    85    72    52    38    -0.7  -1.7  -3.1  -3.2 
   Eastern Europe and Central Asia    68    53    45    37    32    -2.5  -1.6  -1.9  -1.4 
   Latin America and Caribbean  102    86    61    43    31    -1.7  -3.4  -3.4  -3.2 
   Middle East and North Africa  163  131    94    57    46    -2.2  -3.3  -4.9  -2.1 
   South Asia  147  129  115    88    71    -1.3  -1.1  -2.6  -2.1 
      India  146  127  113    84    68    -1.4  -1.2  -2.9  -2.1 
      South Asia excl. India  150  135  121    99    79    -1.0  -1.1  -2.0  -2.3 
   SSA   164  141  116  110*** 104***   -1.5  -1.9  -0.5***  -0.6***
              
World  122 97  79  64  57    -2.3 -2.0 -2.1 -1.2 
World excl. SSA  115  91  72  54  45    -2.3  -2.2  -2.8  -1.9 
World excl. SSA and EECA  119  93  75  56  45    -2.4  -2.2  -2.9  -2.0 
Notes: income countries are not included in the macro regions, e.g. East Asia does not include Japan ** 
these values are influenced by the famine that hit China during the 1959-61 ‘Great Leap Forward’. *** The 
WDI IMR data for SSA for the 1980s and 1990s have been recently revised and describe a less dramatic 
trend in the 1990s. Such revision is however puzzling as a main factor in infant mortality has been the rise 
in HIV adult prevalence rate in the 1990s.  
Source: Authors’ calculations on World Bank (2004) and UNPD (2002). 
 
It has been argued that such a widespread deceleration was due to three factors. First, 
the levelling of vaccination coverage at rates that do not guarantee ‘herd immunity’. 
Second, in regions with IMR below 30-40 per thousand, the slowdown might be due to 
the elimination of all ‘easy-to-remove’ causes of infant death and to the difficulties 
faced in dealing with complex and costly peri-natal problems. Third, the quasi-
stagnation (or, according to other data, the rise) of IMR in SSA was also explained by 
the surge in AIDS deaths among infants. Regression analysis by Cornia and Zagonari 
(2002), for instance, shows that a one percentage rise in HIV adult prevalence rate   11
raised IMR by 0.88 points. This means that in countries with high HIV prevalence (say, 
20 per cent) IMR rose, ceteris paribus, by 17 points per thousand. While pertinent, these 
explanations do not tell the whole story and can hardly explain the slowdown in IMR in 
MENA, the transition economies, China and the high-income countries. A broader set 
of factors is, therefore, likely to have been at play. 
Figure 1: Global and regional trends in DPT3 coverage, 1980-2003 
5  Trends in between-countries distribution of health wellbeing 
The last decade has also witnessed a perceptible increase in between-country health 
inequality, as mortality declined at different rates in different nations. Growing health 
inequality is observed also within most regions, suggesting that the pace of progress 
differed also within groups of countries characterized by similar socioeconomic 
conditions. If continued, this polarization in health wellbeing may lead to rising 
spillovers of ‘international public bads’ (disease, refugees, drugs and illegal migration). 
 
5.1  Rising global and regional inequality in the distribution of (100-LEB) 
Table 3 presents the weighted and unweighted coefficient of variation and Gini 
coefficient21 of the global and regional distributions of 100-LEB for the years 1960, 
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1970, 1980, 1990 and 2000. At the world level, both the coefficient of variation and the 
Gini index follow a U-shaped pattern, with the distribution of 100-LEB converging until 
1990 and then diverging. However, as also suggested by Goesling and Firebaugh 
(2004), such divergence disappears if SSA is removed from the sample, as the fairly 
rapid convergence recorded in South Asia (India and Bangladesh in particular) and 
Central Europe (the Czech Republic and Poland) compensated the divergence registered 
in countries of the former Soviet Union and in nations such as Iraq, North Korea, and 
Haiti.  
Table 3: Trend in the coefficient of variation and Gini coefficient of the intraregional 
and global distribution of 100-LEB, 1960-2000   
 
Coefficient of variation 
(pop. weighted values) 
 
Gini coefficient  (pop. weighted values) 
  1960 1970 1980 1990 2000  1960 1970 1980 1990 2000 
East  Asia  and  Pacific  (22)  0.18 0.16 0.16 0.15 0.15  7.98 7.23 7.48 6.51 6.17 
L.  America  and  Caribbean  (32)  0.12 0.12 0.12 0.12 0.13  6.54 6.17 6.40 6.20 6.49 
Middle East and N. Africa (20)  0.10  0.10  0.10  0.12  0.14    3.61  4.06  4.99  6.06  6.78 
SSA  (45)  0.07 0.08 0.09 0.11 0.09  3.70 4.33 5.10 5.90 4.59 
South  Asia  (7)  0.05 0.06 0.07 0.07 0.08  1.61 1.89 2.11 2.12 1.94 
E. Europe and  C. Asia (29)  0.15  0.13  0.08  0.05  0.10    6.81  5.55  4.18  2.88  5.44 
W.  Europe  (18)  0.05 0.04 0.04 0.04 0.04  2.29 2.12 2.29 2.10 1.92 
North  America  (2)  n.a. n.a. n.a. n.a. n.a.   n.a. n.a. n.a. n.a. n.a. 
World  (175)  0.27 0.24 0.24 0.23 0.27  15.2 13.32  13.19  12.86  14.18 
World excl. SSA (130)  0.28  0.22  0.22  0.20  0.19    15.63  12.57  11.98  10.87  10.31 
World excl. SSA & EECA (101)  0.26  0.22  0.22  0.20  0.20    14.47  12.21  12.32  11.31  10.67 
Memo item: unweighted values               
World  (175)  0.27 0.27 0.28 0.30 0.35  15.4 15.6 16.0 16.8 19.4 
World  excl.  SSA  (130)  0.25 0.24 0.23 0.23 0.24  14.2 13.3 12.5 11.8 12.5 
Notes: the number of countries in each area is in parenthesis. The population of the countries included in 
this analysis represents over 99 per cent of the world population.  
Source: Authors’ calculations on World Bank (2004).  
 
Table 3 shows also that the intraregional dispersion in (100-LEB) followed a U-shaped 
trend in Eastern Europe but a continuously diverging one in most other regions with the 
exception of East Asia and Western Europe which registered a clear convergence. 
Interestingly, in SSA there was a ‘downward convergence’ in 100-LEB between 1990 
and 2000 as the countries that suffered the biggest losses of life expectancy (South 
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countries (i) are ordered by decreasing IMR level, y is the cumulated proportion of infant deaths, and x is 
the cumulated proportion of the infant population. These two indicators of dispersion are scale invariant, 
they are easy to interpreter and are among the most used indicators in the economic literature on 
disparities. This is an important characteristic in the view of a multidimensional analysis of disparities in 
wellbeing. Moreover the Gini index is increasingly used in the study of health inequalities and some 
adaptation to health indicators have been elaborated (e.g. for IMR).   13
Africa, Botswana and so on) were those which had the highest LEB in the 1980s. 
Except for East Asia, that is dominated by China, these trends are more pronounced 
when the coefficient of variation and the Gini index are computed without weighing the 
life expectancy data by population size. An analysis of health dispersion trends making 
use of the variable 90-LEB (instead of 100-LEB) shows that divergence in global health 
distribution start emerging in the 1980 (rather than in 1990) but confirms the U-shaped 
pattern of health inequality trends and that the 1990s was the decade with the strongest 
rise of inter-regional and global health inequality. 
 
It must finally be noted that when the coefficients of dispersion are computed without 
weighing country data for population size, the global divergence in health inequality 
persists in the 1990s even after removing SSA from the sample (bottom of Table 3). All 
this means that, in terms of countries rather than people, the derailment of long-term 
convergence in life expectancy predicted by Preston (1976) and Wilson (2001) is due to 
factors other than the spread of HIV/AIDS, stagnation and conflicts in Africa. This is a 
key point noted in McMichael et al. (2004) that should be brought to the attention of 
policymakers. 
 
Goesling and Firebaugh (2004) have suggested that rising global inequality in 100-LEB 
(the ‘actual change’) may be due more to faster population growth in regions 
characterized by higher values of 100-LEB (the ‘population effect’) than to differences 
in the rate of change in 100-LEB itself (the ‘growth effect’). To test this hypothesis, the 
observed change in the Gini coefficient of the distribution of 100-LEB was decomposed 
into these components. The results in Table 4 indicate that differences in population 
growth explain a small part of the global changes both for the world as a whole and for 
the World excluding SSA. Most of the rise in the Gini coefficient is imputable to the 
‘growth effect’.  
Table 4: Decomposition of yearly changes in Gini of 100-LEB (‘actual change’) into the 
‘population effect’ and ‘growth effect’ (% changes) 
   1970-80 1980-90  1990-2000
actual change  -0.10 -0.25  0.98
growth effect  -0.01 -0.22  0.83 World 
Population effect  -0.19 -0.09  0.07
    
actual change  -0.48 -0.97  -0.53
growth effect  -0.37 -0.84  -0.51 World excluding SSA 
Population effect  -0.18 -0.11   0.02
Note: The ‘growth effect’ is the average yearly change in the Gini coefficient of the global distribution of 
100-LEB using the countries’ population weights of 1970. The ‘population effect’ is the average yearly 
change in the Gini coefficient of the global distribution of 100-LEB keeping the level of the countries’ 100-
LEB at its 1970 value. 
Source: Authors’ calculation based on World Bank (2004).   14
5.2  Increasing global and intraregional dispersion in the distribution of IMR 
Table 5 presents the trend of the coefficient of variation and of the Gini coefficient of 
the population-weighed regional and global IMR distributions for the years 1960, 1970, 
1980, 1990 and 2000. The table confirms that, because of country differences in rates of 
IMR reduction (Table 2), the coefficient of variation and Gini index of the global 
distribution of IMR have shown a clear upward trend from 1980 onward, while during 
the prior two decades there was only a modest increase. This trend is robust, if in a 
slightly attenuated way, to the removal of SSA and Eastern Europe from the sample. 
This means that the gains in IMR recorded during the last two decades have been 
distributed in an increasingly unequal way across countries and that several of them 
have been left behind. 
 
Divergence in the global distribution of IMR is found also when the analysis is 
conducted on unweighted data. Removing SSA from the sample does not alter visibly 
this result (bottom of Table 5). Thus, also in this case, SSA accounts for part of the rise 
in IMR divergence but not for its entirety. Other forces are hampering the decline of 
IMR in several regions. 
 
Table 5: Coefficient of variation and Gini coefficient of the intraregional and global 
distribution of IMR 
 
Coefficient of variation 
(pop. weighted values) 
 Gini  coefficient 
(pop. weighted values) 
  1960 1970 1980 1990 2000   1960 1970 1980 1990 2000 
East  Asia  and  Pacific  (22)  0.31*  0.28 0.38 0.39 0.46   15.2*  12.5 18.4 17.1 17.8 
L.  America  and  Caribbean  (27)  0.26 0.26 0.34 0.38 0.40   14.2 13.8 18.0 19.9 19.7 
Middle  East  and  N.  Africa  (20)  0.21 0.26 0.29 0.37 0.56   10.6 13.5 15.6 20.3 28.4 
SSA  (45)  0.24 0.23 0.25 0.28 0.25   12.8 13.0 13.9 15.3 13.8 
South  Asia  (8)  0.09 0.11 0.13 0.17 0.27   2.50 4.0  4.4  5.3  8.8 
Eastern  Europe  and  C.Asia  (26) 0.57 0.78 0.68 0.60 0.61   28.5 38.8 33.8 31.9 32.9 
Western  Europe  (18)  0.37 0.35 0.26 0.14 0.18   19.0 17.5 12.6 6.5  9.4 
North  America  (2)  n.a. n.a. n.a. n.a. n.a.   n.a. n.a. n.a. n.a. n.a. 
              
World  (168)  0.41*  0.43 0.51 0.57 0.64       22.2*  24.0 29.0 33.1 35.1 
World excl. SSA (123)  0.42*  0.44  0.53  0.55  0.61        22.6* 24.3  30.1  30.5  32.6 
World excl. SSA&EECA (97)  0.39*  0.41  0.51  0.54  0.60        20.4* 22.4  28.8  29.7  32.1 
Memo item: unweighted values                
World  (168)  0.54*  0.61 0.71 0.82 0.90   30.2*  35.1 39.9 44.8 48.8 
World  excl.  SSA  (123)  0.58*  0.67 0.77 0.85 0.96   32.9*  37.3 41.5 44.5 48.3 
Notes: * these values are influenced by the famine that hit China during the 1958-61 ‘Great Leap Forward’. 
The number of countries in each area is in parenthesis. The population of the countries included in this 
analysis represents over 99 per cent of the World infants’ population. 
Source: authors’ calculations on World Bank (2004). 
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Rising inequality in the distribution of IMR since 1980 is evident also in MENA, South 
Asia, East Asia and Latin America. In the first three of these regions, the fastest increase 
in intraregional divergence in IMR took place over 1990-2000, a period characterized 
by slow and volatile growth, mounting income inequality and stagnant or declining 
coverage of key public health programmes in favour of children. The exception to this 
rule are the two ‘crisis regions’ of Eastern Europe and SSA both of which show 
fluctuating trends characterized by a ‘downward convergence’ in IMR in the 1980s and 
1990s, as in both regions the worst performance was recorded in countries with already 
fairly low IMR levels. In contrast, the distribution of national IMRs improved steadily 
in Western Europe (save for a blip over 1990-2000 that disappears when using 
unweighted data) confirming the findings about the policy-driven equalization of health 
wellbeing in the region.22 
 
To conclude, the analysis of IMR convergence confirms—more markedly than in the 
case of 100-LEB—that the recent global and intraregional health gains were distributed 
in an increasingly less egalitarian way, particularly over the 1990s. This conclusion is 
robust to the choice of different inequality and health indicators, and to the weighting of 
national indicators by means of appropriate populations.  
6  Trends in the within-country distribution of health wellbeing  
This kind of analysis is made possible by the increase in the number of countries23 with 
at least two demographic and health surveys24 over the last twenty years. These surveys 
permit, in principle to carry out assessments of changes in health differentials on the 
basis of several indicators. Information gaps, however, limit such choice and, for this 
reason, the analysis will focus exclusively on IMR25 differentials for children belonging 
to different quintiles of the income distribution or residing in urban versus rural areas. 
Analysis of changes in IMR differentials by level of education of the mother is possible 
in principle but is biased by the under-sampling of highly educated mothers, and is thus 
omitted from the analysis.  
                                                 
22 Micklewright and Stewart (1999). 
23 The countries with at least two DHS surveys are, at this date, about 40. The 26 countries included in 
this analysis are Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Kenya, Madagascar, Malawi, 
Mali, Niger, Nigeria, Rwanda, Senegal, Tanzania, Togo, Uganda, Zambia, Zimbabwe, Brazil, Colombia, 
Dominican Republic, Egypt, India, Bangladesh, The Philippines and Indonesia. The size of the DHS 
samples vary considerably not only between countries (ranging from 92,486 households coverage by the 
1998/99 DHS for India to 1,381 households of the 1999 DHS in the Dominican Republic) but also 
between different rounds of DHS in the same country (for example in Malawi the households covered by 
the survey were 2,798 in 1996 and 14,213 in 2000).  
24 DHS are large-scale nationally representative household surveys of varying sample size. This analysis 
used data on children based on interview of women aged 15-49 or 15-44 containing information about 
births and surviving children of 60 (or 36) months of age at the time of the survey. 
25 The IMRs used in the analysis of differentials by rural–urban are calculated dividing the number of 
infant deaths under one year of age by the number of births in the five complete years preceding the 
survey, considering also half of the deaths occurred at age 12 months, which strictly speaking is included 
in the second year of life, but which probably occurred in the first year. In contrast, the mortality 
differentials by the asset index are computed on the ten years preceding the survey.   16
6.1  Trends in IMR differentials by income level 
As shown in the literature (see section 3), DHS now permit to estimate the mortality risk 
of infants ranked by an ‘asset index’ that proxies household income. In this regard, 
Table 6 presents the values of IMR at two different points in time for 16 developing 
countries, both for the sample’s average and for the bottom and top quintile of the 
household asset distribution. The table provides also two measures of dispersion, i.e. the 
interquitile ratio (IQR), the ratio of the IMR of children belonging to the bottom and top 
quintiles of the asset distribution, and the concentration coefficient (CC) of the same 
distribution. While the former index captures changes in the tails of the IMR 
distribution, the latter is more sensitive to changes affecting the three central quintiles. 
 
Table 6: Trends in IMR and IMR differentials for 16 developing countries, 1990s and 










































Turkey (1993, 1998)  68.3 99.9 25.4 3.9 48.4 68.3 29.8 2.3  decline  decline 
Kazakhstan (1995, 1999)  40.7 39.2 35.1 1.1 54.9 67.6 42.3 1.6  rise  rise 
Colombia (1995, 2000)  30.8 40.8 16.2 2.5 24.4 32.0 17.6 1.8  decline  rise 
Guatemala (1995, 1998)  57.2  56.9 35.0 1.6 49.1 58.0 39.2 1.5  decline  constant 
Haiti (1994-95, 2000)  87.1  97.3 74.3 1.3 89.4 99.5 97.2 1.0  decline  decline 
Nicaragua (1997-98, 2001)  45.2  50.7 25.8 1.9 35.3 49.6 16.3 3.0  rise  rise 
Peru (1996, 2000)  49.9  78.3 19.5 4.0 43.2 63.5 13.9 4.6  rise  – 
Egypt (1995, 2000)   72.9  109.7 31.8 3.4 54.7 75.6 29.6 2.6  decline  decline 
Bangladesh (1996-97, 1999-2000)  89.6  96.5 56.6 1.7 79.7 92.9 57.9 1.6  decline  rise 
India (1992-93, 1999)  86.3  109.2 44.0 2.5 73.0 96.5 38.1 2.5  constant  – 
Nepal (1996, 2001)  93.0  96.3 63.9 1.5 77.2 85.5 53.2 1.6  rise  rise 
Cameroon (1991,1998)  80.3  103.9 51.2 2.0 79.8 108.4 55.8 1.9  decline  – 
Ghana (1993, 1998)  74.7  77.5 45.8 1.7 61.2 72.7 26.0 2.8  rise  rise 
Malawi (1992, 2000)  136.1  141.2 106.1 1.3 112.5 131.5 86.4 1.5  rise  rise 
Mali (1995, 2001)  133.5  151.4 93.2 1.6 126.2 137.2 89.9 1.5  decline  rise 
Uganda (1995, 2000-01)  86.1  109.0 63.2 1.7 89.4 105.7 60.2 1.8  rise  – 
Note: the IMRs are calculated over the 10 years preceding the survey. 
Source: authors’ elaboration on data provided by the World Bank, Health, Nutrition, Population and 
Poverty Division (www.worldbank.org/hnp).  
 
 
The evidence presented in Table 6 shows that average IMR fell over time in 12 of the 
16 countries analyzed, stagnated in 1 and worsened in 3. Progress in average IMR, 
however, was accompanied in 60 per cent of the cases by a rise in IMR inequality   17
indexes that are used here jointly as they provide different information about health 
inequality.26 
 
A cross-tabulation of changes in average IMR and IMR inequality (Table 7) further 
shows that in many instances an average IMR improvement was accompanied by 
growing or unchanged IMR inequality. The upper right box of Table 7 shows, for 
instance, that in 12 cases concerning eight countries most of the IMR decline benefited 
children from higher quintiles. In three cases concerning two countries IMR inequality 
worsened, as expected, in parallel with a rise in average IMR while in another three 
IMR inequality fell despite a rise in IMR. These results confirm the findings of Minujin 
and Delamonica (2003) for the mid 1980s and mid 1990s about a widespread rise in 
U5MR inequality despite a fall in the mean. 
 
Table 7: Cross tabulation of changes in average IMR versus the interquartile ratio 
(IQR) and concentration coefficient (CC) for 26 inequality changes concerning 16 
countries 




Turkey IQR, Turkey CC 
Colombia IQR 
Guatemala IQR 






Nicaragua IQR, Nicaragua CC 
Peru IQR, Bangladesh CC  
Nepal IQR,  Nepal CC 
Ghana IQR  Ghana CC 














Haiti IQR, Haiti CC    Kazakhstan IDR,  
Kazakhstan CC 
Uganda IQR  
Note: changes of less than 4 per cent are assumed to indicate that the variable remained constant. 
Source: Authors’ compilation on the basis of the data report in Table 6.  
 
6.2  Trends in IMR differentials by rural vs. urban residence 
In this case the rural–urban IMR differentials were calculated on DHS surveys spanning 
the period 1985-99. DHS analysts normally compute IMR differentials over a 10-year 
period so as to enlarge the sample and reduce the estimation error. This procedure has 
the disadvantage, however, to preclude practically all analyses of changes in IMR levels 
and differentials for an entire decade. For this reason, the IMR differentials were 
computed for 5-year periods so as to be able to capture the changes in IMR over the 
                                                 
26 The worsening of IMR differentials was more frequent in the case of the concentration coefficient.   18
1990s, and because when a longer period is chosen there is a higher risks that the 
mothers included in the sample are age selected and that recall errors will be larger. The 
decision to compute IMR differentials for 5-year periods, however, reduces the sample 
size and may affect the stability of IMR estimates. As in other cases, the data may also 
be affected by errors common in this kind of survey, such as omission of registrations, 
misreporting of age, recall error, and so on. Be as it may, the analysis was conducted 
assigning each survey to four sub-periods 1985-90, 1991-95, 1996-2000 and 2001-03 
(Table 8). 
 
Table 8: IMR national level and rural–urban IMR ratio in selected countries  
  1985-90 1991-95  1996-2000  2001-03 
  IMR R/U IMR R/U IMR  R/U  IMR R/U 
Benin      98  1.19  94  1.55 
Burkina Faso      103  1.56  114  1.79     
Cameroon     67  1.10  83  1.39     
Cote d'Ivoire      91  1.21  117  1.42     
Ghana  89 1.33  71 1.31  60  1.61  68 1.31 
Kenya     65  1.22  68  1.38  80  1.31 
Madagascar   98  1.47  100  1.19     
Malawi     143  1.11  110  1.62     
Mali 123  1.54      130  1.49  128  1.25 
Niger     136  1.67  130  1.77     
Nigeria 96  1.25      83  1.26     
Rwanda     88  0.97  114  1.51     
Senegal     71  1.68  74  1.54     
Tanzania     95  0.76  93  1.29  103  1.05 
Togo 87  1.08      84  1.32     
Uganda 108  1.03  86  1.15      92  1.78 
Zambia     111  1.32  116  1.09  100  1.21 
Zimbabwe  52 1.51  55 1.3  70  1.15     
Brazil 75  1.82      40  1.86     
Colombia  35 1.02  29 1.22  22  1.12     
Dominican  Rep.  70 1.03  44 1.46  47  1.28  32 1.15 
Egypt     64  1.73  45  1.34  39  1.41 
India     81  1.52  78  1.57     
Bangladesh     91  1.52  84  1.11  68  1.07 
The Philippines    36  1.46  37  1.27     
Indonesia     71  1.47  47  1.52  35  1.63 
Source: Authors’ calculations on selected DHS. 
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Table 8 shows that in the mid-to-late 1980s, the majority of the SSA countries had fairly 
high average IMR but moderate rural–urban gap, ranging between 1.03 and 1.5. 
Differentials were somewhat more pronounced in Brazil where the rural–urban IMR 
ratio exceeded 1.8. In many cases, the changes observed between the 1980s and 1990s 
point to an exacerbation of such differentials though in some cases the gap narrowed. 
Altogether, in thirteen cases out of the 26 sample countries the rural–urban IMR ratio 
worsened between the first and last survey, in four it remained broadly unchanged and 
in nine it narrowed. In Indonesia the rural–urban gap worsened despite a decline in the 
nationwide IMR, while the opposite was true in Bangladesh and the Philippines. The 
three Latin American countries in the sample show moderate deterioration or stagnation 
between the initial and final year. As a whole, the trends observed in SSA do not permit 
to identify a clear relation between IMR reduction and rural–urban IMR convergence. 
Generally speaking, rural areas continue to be disadvantaged with respect to infant 
health. In all cases, a greater focus on rural areas would have allowed to achieve a faster 
overall decline in IMR—and a more balanced distribution of health wellbeing. 
 
Table 9: Cross tabulation of IMR changes in relation to changes in the rural–urban (r/u) 
IMR ratio in selected developing countries, mid-late 1980s to early 2000s  














Madagascar,  Mali, The 
Philippines, Senegal,  
Tanzania 







Cote d’Ivoire,  
Rwanda,  
6 
  9 4 13  26 
Note: Changes of less than 4 per cent are taken to indicate that the variable has remained constant. 
Source: Author’s elaboration on selected DHS. 
 
Also in this case, a cross-tabulation of changes in average IMR versus the rural–urban 
IMR differentials in Table 9 shows there are many off-diagonal observations. In fact, 
eleven countries located above the main diagonal recorded worse-than-expected 
changes in IMR differentials, i.e. stable or rising IMR differential on occasion of 
average improvements, or a worsening of this ratio on occasion of a stagnation of 
average IMR. In contrast, there were only six countries below the main diagonal 
showing better-than-expected results. All this points to a comparatively high frequency 
of deteriorations in the urban–rural IMR ratio explained by the faster progress realized 
in urban areas and revealing the limits of location-neutral policies.    20
7  Conclusions and indications for further research  
The data problems mentioned throughout this paper suggest caution in interpreting the 
above results. Yet, the above discussion points to a few important conclusions, some 
fairly robust, some still tentative. To start with, over the last twenty years the rate of 
improvement in health wellbeing slowed down in relation to that recorded in the 1960s 
and 1970s. In developing and transitional countries, the slowdown was most 
pronounced in the 1990s. However, there are important exceptions to this rule (such as 
MENA and Latin America in the 1980s) that need to be investigated in greater detail to 
identify the factors that permitted continuing progress in health wellbeing in spite of flat 
or negative growth and, in the case of Latin America, rising inequality. Yet, the 
slowdown in rates of progress was sufficiently general to suggest the effect of some 
systemic factors. Indeed, the slowdown is robust to the removal of SSA and Eastern 
Europe from the sample, thus invalidating the viewpoint that attributes the current 
slowdown to the difficulties of the transition in Eastern Europe and the spread of AIDS, 
civil conflicts and economic stagnation in SSA. Thus, though with some exceptions and 
differences in time profiles, the slowdown in aggregate rates of improvement in health 
wellbeing in the 1908s and 1990s seems to be fairly general.  
 
Second, there is clear evidence that the between-country distribution of health wellbeing 
has become more skewed. This conclusion holds also after removing SSA and Eastern 
Europe from the sample. In addition, with the exception of Western Europe and East 
Asia (in the case of 100-LEB) and of Western Europe and Eastern Europe (in the case 
of IMR), the intraregional distribution of health gains has become increasingly less 
egalitarian. These are important conclusions as, so far, there is little agreement in the 
literature on the wellbeing convergence over the last two decades. The paper also 
suggests that where public policy actively aimed at reducing wellbeing differentials, as 
in the EU, health wellbeing converged steadily.  
 
Finally, the within-country distribution of health wellbeing by an asset index and rural–
urban location appears to have worsened in about 50-60 per cent of the cases analyzed. 
Such trends need however to be confirmed on a longer time period and bigger samples 
but seem to corroborate the results mentioned at the beginning about the worsening of 
the income distribution.  
 
What are the factors behind these changes in health wellbeing? In view of data problems 
and the level of aggregation of the analysis, the points made below are at times 
speculative and must be taken as hypotheses to be tested by detailed analyses rather than 
firm conclusions on causality. To start with, there is no doubt that the spread of 
HIV/AIDS affected in a major way trends in IMR and 100-LEB in SSA and a few 
Caribbean countries and that—barring new breakthroughs in medical research and drugs 
availability—HIV/AIDS will continue to affect negatively health wellbeing trends in 
these countries in the years ahead. It is important to note in this regard that, as in the 
1990s, future AIDS-related mortality  will be influenced by the way globalization (and 
in particular the TRIPS agreement) will affect the cost and transfer of health technology 
(anti-retrovirals in particular) in the areas affected by the pandemic. As noted by Deaton   21
(2004), if this transfer is delayed or is too costly, mortality differentials across regions 
will continue to diverge because of these policies.  
 
Yet, it is not possible to place all the blame for the unsatisfactory health performance of 
the last decade on HIV/AIDS, especially in countries with low HIV prevalence but a 
record of slow health improvements and growing health inequality. In this regard, a 
second possible cause of the slow health improvement and growing divergence in health 
wellbeing are changes in health spending and key health programmes. The debate about 
globalization has often highlighted the risk posed to revenue collection by liberal tax 
reforms, tax competition among developing countries and the globalization-driven 
outsourcing and informalization of the economy. Yet, the evidence on revenue 
collection and public expenditure is mixed. While there are examples of countries (such 
as China and the economies in transition) that restricted public health expenditure and 
access to health services, in others (from MENA and Latin America) public health 
expenditure increased or remained constant at relatively high levels. However, public 
health expenditure may be too noisy a variable to affect mortality rates. In contrast, an 
expansion of key public health programmes such as child immunization, oral 
rehydration, provision of antibiotics, and pregnancy control, can deliver important 
health gains even during periods of stagnant health expenditure. Symmetrically, a 
stagnation or decline in the coverage of such programmes (as often observed in the 
1990s for immunization) may have affected adversely IMR and LEB even in the 
presence of an expanding health budget.  
 
Third, mortality has also been affected by a rising wave of local conflicts and natural 
disasters. Those of Afghanistan, Angola, Bosnia, Burundi, Cambodia, Ethiopia, 
Guatemala, Iraq, North Korea, Rwanda, Somalia, Sri Lanka and Sudan are just a few of 
the 50 or so humanitarian crises in which death rates soared markedly. Yet, only crude 
estimates of the health impact of such crises are available and only in few cases is it 
possible to fully capture the impact of these tragic events on mortality trends, as existing 
databases generally underreport their impact.   
 
Fourth, changes in the structure and stability of households—and in social cohesion 
more generally—may have also affected, if more subtly, current health trends. The 
traditional family has in fact been eroded in many places thus exposing its members to 
greater health risks, as suggested by micro studies that identify a greater death risk of 
children, elderly and adults living in incomplete families. In this regard, the last twenty 
years have seen a rise in the number of people living in incomplete households because 
of divorce, separation, lone parenthood, singlehood, migration and premature death of 
the parents or of a spouse. Single-parent families represent 10-15 per cent of all OECD 
families with dependent children and a higher percentage in Latin America, the Caribbean 
and parts of South East Asia. Such trend has surfaced even in China where traditional 
values usually left no space for such types of family arrangement. In turn, in the HIV-
affected countries the number of orphans exposed to risk of non-AIDS-related mortality 
has risen well above the level that can be handled through extended family arrangements. 
In other countries, such as Bosnia and Ethiopia, war and ethnic conflicts have caused a 
sharp increase in the number of incomplete families. Meanwhile in Russia, Moldova and   22
other economies in transition, the number of biological or social orphans has risen rapidly 
because of soaring parental mortality, migration and child abandonment.  
 
Last but not least, a host of empirical data and theoretical arguments suggest that health 
trends have been affected by the slow or negative growth and soaring income inequality 
observed over the last twenty years in many developing and transition countries that 
adopted botched liberalization and globalization policies such as loose bank 
deregulation, premature external liberalization and regressive tax reforms. Indeed, both 
theory and empirical evidence show that slower growth, greater income inequality and 
rising volatility affect health and health inequality.27 The precise extent and 
mechanisms of such impact remain however undocumented in most cases. This is a 
priority area for research in which existing theories linking growth and income 
inequality to health and health inequality have to be tested on enlarged datasets and time 
periods. Perhaps, this new research will help bringing about a more humane 
globalization promoting faster health progress and health convergence over the next 
decades. 
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